PHARMACOKINETICS AND CLINICAL EVALUATION ON CEFOTIAM IN PEDIATRIC SURGERY

  • YURA JIRO
    The 1st Department of Surgery, Nagoya City University Medical School
  • TSURUGA NOBUATSU
    The 1st Department of Surgery, Nagoya City University Medical School
  • HASHIMOTO TAKASHI
    The 1st Department of Surgery, Nagoya City University Medical School
  • KAMIYA YASUHIRO
    The 1st Department of Surgery, Nagoya City University Medical School
  • HAYASHI SHUSAKU
    The 1st Department of Surgery, Nagoya City University Medical School
  • MURATA YUKITAKA
    The 1st Department of Surgery, Nagoya City University Medical School

Bibliographic Information

Other Title
  • 小児外科領域におけるCefotiamの基礎的, 臨床的評価

Search this article

Abstract

Pharmacokinetics and clinical studies on cefotiam (CTM) in pediatric surgery were performed and the results obtained are summarized below.<BR>1. In neonates without congenital heart disease (CHD), serum levels of CTM were rapidly increased following injection of CTM (20mg/kg, one shot intravenous administration) and the peak values were found at 15 minutes. Six hours later, CTM almost disappeared from the blood. In:the patient with CHD, however, CTM was retained in the serum and the urinary excretion was poor.<BR>2. The CTM was administrated prophylactically to prevent postoperative infections in 10 patients. Eight of 10 had no episodes during postoperative period. Wound infection, however, was found in 2 patients. No clinical and laboratory side effects were caused by CTM.

Journal

Details 詳細情報について

Report a problem

Back to top